Smeenk D - Search Results

1

Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.

Schelfhout LJ, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, van de Velde CJ, Goslings BM. Schelfhout LJ, et al. Among authors: smeenk d. Eur J Cancer Clin Oncol. 1988 Feb;24(2):331-7. doi: 10.1016/0277-5379(88)90276-3. Eur J Cancer Clin Oncol. 1988. PMID: 3356216

2

The relationship between serum protein-bound iodine levels and urinary iodine excretion and serum thyrotrophin concentrations in subjects from an endemic goitre area in central Java.

Hennemann G, Djokomoeljanto R, Docter R, Goslings BM, van Hardeveld C, Smeenk D, Querido A. Hennemann G, et al. Among authors: smeenk d. Acta Endocrinol (Copenh). 1978 Jul;88(3):474-81. doi: 10.1530/acta.0.0880474. Acta Endocrinol (Copenh). 1978. PMID: 79291 No abstract available.

3

Hypothyroidism in an area of endemic goiter and cretinism in Central Java, Indonesia.

Goslings BM, Djokomoeljanto R, Docter R, van Hardeveld C, Hennemann G, Smeenk D, Querido A. Goslings BM, et al. Among authors: smeenk d. J Clin Endocrinol Metab. 1977 Mar;44(3):481-90. doi: 10.1210/jcem-44-3-481. J Clin Endocrinol Metab. 1977. PMID: 65359

4

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring.

van Slooten H, Moolenaar AJ, van Seters AP, Smeenk D. van Slooten H, et al. Among authors: smeenk d. Eur J Cancer Clin Oncol. 1984 Jan;20(1):47-53. doi: 10.1016/0277-5379(84)90033-6. Eur J Cancer Clin Oncol. 1984. PMID: 6537915

5

Morphologic characteristics of benign and malignant adrenocortical tumors.

van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ. van Slooten H, et al. Among authors: smeenk d. Cancer. 1985 Feb 15;55(4):766-73. doi: 10.1002/1097-0142(19850215)55:4<766::aid-cncr2820550414>3.0.co;2-7. Cancer. 1985. PMID: 3967172

6

O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.

von Slooten H, van Seters AP, Smeenk D, Moolenaar AJ. von Slooten H, et al. Among authors: smeenk d. Cancer Chemother Pharmacol. 1982;9(2):85-8. doi: 10.1007/BF00265384. Cancer Chemother Pharmacol. 1982. PMID: 7172409

7

Blood levels of o,p'-DDD following administration in various vehicles after a single dose and during long-term treatment.

Moolenaar AJ, van Slooten H, van Seters AP, Smeenk D. Moolenaar AJ, et al. Among authors: smeenk d. Cancer Chemother Pharmacol. 1981;7(1):51-4. doi: 10.1007/BF00258213. Cancer Chemother Pharmacol. 1981. PMID: 7340988

8

Bone changes associated with glucocorticoid excess.

Birkenhäger JC, van der Heul RO, Smeenk D, van der Sluys Veer J, van Seters AP. Birkenhäger JC, et al. Among authors: smeenk d. Proc R Soc Med. 1967 Nov 1;60(11 Part 1):1134-6. Proc R Soc Med. 1967. PMID: 6060708 Free PMC article. No abstract available.

9

[Vitamin D-resistant osteomalacia with neurofibromatosis].

SMEENK D, KASSENAAR AA, QUERIDO A. SMEENK D, et al. Ned Tijdschr Geneeskd. 1955 Nov 19;99(47):3560-3. Ned Tijdschr Geneeskd. 1955. PMID: 13288641 Dutch. No abstract available.

10

[Chronic primary adrenal insufficiency].

DE COCK J, DE GRAEFF J, SMEENK D, QUERIDO A. DE COCK J, et al. Among authors: smeenk d. Ned Tijdschr Geneeskd. 1957 Dec 21;101(51):2426-37. Ned Tijdschr Geneeskd. 1957. PMID: 13504333 Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters